Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Nature Reviews. Urology|November 13, 2019
Radium-223 mechanism of action: implications for use in treatment combinationsMichael J Morris, Eva Corey, Theresa A Guise, et al.
Chemmedchem|November 7, 2015
Modular Assembly of Allosteric MEK Inhibitor Structural Elements Unravels Potency and Feedback-Modulation HandlesIngo V Hartung, Florian Pühler, Roland Neuhaus, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2013
Optimization of allosteric MEK inhibitors. Part 1: Venturing into underexplored SAR territoriesIngo V Hartung, Marion Hitchcock, Florian Pühler, et al.
Neuroendocrinology|November 21, 2007
An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expressionLars Stelter, Holger Amthauer, Annett Rexin, et al.
The American Journal of Gastroenterology|June 22, 2007
Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinomaArne Scholz, Vanessa Annina Rehm, Svenja Rieke, et al.
Frontiers in Medicine|February 2, 2023
Targeted thorium-227 conjugates as treatment options in oncologyJenny Karlsson, Christoph A Schatz, Antje M Wengner, et al.
International Journal of Molecular Sciences|January 8, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer ModelsUrs B Hagemann, Christoph A Schatz, Mari I Suominen, et al.
Journal of the National Cancer Institute|May 18, 2013
Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasisMari I Suominen, Jukka P Rissanen, Rami Käkönen, et al.
International Journal of Molecular Sciences|February 11, 2023
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer ModelMari I Suominen, Matias Knuuttila, Christoph A Schatz, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 8, 2020
Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha TherapyUrs B Hagemann, Katrine Wickstroem, Stefanie Hammer, et al.
Pageof 5